Basic Information
| RNALocate ID: | RLID:11003021 |
| RNA Symbol: | hsa-miR-181d-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-181d |
| RNA ID: | miRBase:MIMAT0002821 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002349 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11003019 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11003020 | Exosome | Brain tissue | 23382797 |
| RLID-D:11000156 | Exosome | Blood | |
| RLID-D:11000488 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-181d-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-20114 |
| MNDR | hsa-miR-181d-5p | Medulloblastoma | MNDR-E-MI-20115 |
| MNDR | hsa-miR-181d-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-20116 |
| MNDR | hsa-miR-181d-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-20117 |
| MNDR | hsa-miR-181d-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-20118 |
| MNDR | hsa-miR-181d-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-20119 |
| MNDR | hsa-miR-181d-5p | Her2-receptor positive breast cancer | MNDR-E-MI-20120 |
| MNDR | hsa-miR-181d-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-20121 |
| MNDR | hsa-miR-181d-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-20122 |
| MNDR | hsa-miR-181d-5p | Small intestine cancer | MNDR-E-MI-20123 |
| MNDR | hsa-miR-181d-5p | Prostate cancer | MNDR-E-MI-20124 |
| MNDR | hsa-miR-181d-5p | Gastric cancer | MNDR-E-MI-20125 |
| MNDR | hsa-miR-181d-5p | Alzheimer disease | MNDR-E-MI-20126 |
| MNDR | hsa-miR-181d-5p | Bladder cancer | MNDR-E-MI-20127 |
| MNDR | hsa-miR-181d-5p | Head and neck cancer | MNDR-E-MI-20128 |
| MNDR | hsa-miR-181d-5p | Leukemia | MNDR-E-MI-20129 |
| MNDR | hsa-miR-181d-5p | Huntington disease | MNDR-E-MI-20130 |
| MNDR | hsa-miR-181d-5p | Chorea | MNDR-E-MI-20131 |
| MNDR | hsa-miR-181d-5p | Cardiovascular disease | MNDR-E-MI-20132 |
| MNDR | hsa-miR-181d-5p | Lung cancer | MNDR-E-MI-20133 |
| MNDR | hsa-miR-181d-5p | Fragile x syndrome | MNDR-E-MI-20134 |
| MNDR | hsa-miR-181d-5p | Parkinson disease | MNDR-E-MI-20135 |
| MNDR | hsa-miR-181d-5p | Breast cancer | MNDR-E-MI-20136 |
| MNDR | hsa-miR-181d-5p | Pancreatic cancer | MNDR-E-MI-20137 |
| MNDR | hsa-miR-181d-5p | Melanoma | MNDR-E-MI-20138 |
| MNDR | hsa-miR-181d-5p | Rectum adenocarcinoma | MNDR-E-MI-20139 |
| MNDR | hsa-miR-181d-5p | Nephroblastoma | MNDR-E-MI-20140 |
| MNDR | hsa-miR-181d-5p | Colon cancer | MNDR-E-MI-20141 |
| MNDR | hsa-miR-181d-5p | Colon adenocarcinoma | MNDR-E-MI-20142 |
| MNDR | hsa-miR-181d-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-20143 |
| MNDR | hsa-miR-181d-5p | Familial ovarian cancer | MNDR-E-MI-20144 |
| MNDR | hsa-miR-181d-5p | Prostate adenocarcinoma | MNDR-E-MI-20145 |
| MNDR | hsa-miR-181d-5p | Carcinoma ductal breast | MNDR-E-MI-20146 |
| MNDR | hsa-miR-181d-5p | Glioblastoma | MNDR-E-MI-20147 |
| MNDR | hsa-miR-181d-5p | Glioma | MNDR-E-MI-20148 |
| MNDR | hsa-miR-181d-5p | Nemaline myopathy | MNDR-E-MI-20149 |
| MNDR | hsa-miR-181d-5p | Epilepsy temporal lobe | MNDR-E-MI-20150 |
| MNDR | hsa-miR-181d-5p | Osteosarcoma | MNDR-E-MI-20151 |
| MNDR | hsa-miR-181d-5p | Breast carcinoma | MNDR-E-MI-20152 |
| MNDR | hsa-miR-181d-5p | Cervical squamous cell carcinoma | MNDR-E-MI-20153 |
| MNDR | hsa-miR-181d-5p | Lung squamous cell carcinoma | MNDR-E-MI-20154 |
| MNDR | hsa-miR-181d-5p | Thyroid carcinoma | MNDR-E-MI-20155 |
| MNDR | hsa-miR-181d-5p | Ovarian carcinoma | MNDR-E-MI-20156 |
| MNDR | hsa-miR-181d-5p | Pancreatic adenocarcinoma | MNDR-E-MI-20157 |
| MNDR | hsa-miR-181d-5p | Carcinoma renal cell | MNDR-E-MI-20158 |
| MNDR | hsa-miR-181d-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-20159 |
| MNDR | hsa-miR-181d-5p | Clear cell renal cell carcinoma | MNDR-E-MI-20160 |
| MNDR | hsa-miR-181d-5p | Cholangiocarcinoma | MNDR-E-MI-20161 |
| MNDR | hsa-miR-181d-5p | Esophageal cancer | MNDR-E-MI-20162 |
| MNDR | hsa-miR-181d-5p | Lung small cell carcinoma | MNDR-E-MI-20163 |
| MNDR | hsa-miR-181d-5p | Synovial sarcoma | MNDR-E-MI-20164 |
| MNDR | hsa-miR-181d-5p | T acute lymphoblastic leukemia | MNDR-E-MI-20165 |
| MNDR | hsa-miR-181d-5p | Acute t cell leukemia | MNDR-E-MI-20166 |
| MNDR | hsa-miR-181d-5p | Breast invasive carcinoma | MNDR-E-MI-20167 |
| MNDR | hsa-miR-181d-5p | Hepatocellular carcinoma | MNDR-E-MI-20168 |
| MNDR | hsa-miR-181d-5p | Familiar ovarian carcinoma | MNDR-E-MI-20169 |
| MNDR | hsa-miR-181d-5p | Rheumatoid arthritis | MNDR-E-MI-20170 |
| MNDR | hsa-miR-181d-5p | Neuromyelitis optica | MNDR-E-MI-20171 |
| MNDR | hsa-miR-181d-5p | Acute myelocytic leukemia | MNDR-E-MI-20172 |
| MNDR | hsa-miR-181d-5p | Colorectal cancer | MNDR-E-MI-20173 |
| MNDR | hsa-miR-181d-5p | Nasopharynx carcinoma | MNDR-E-MI-20174 |
| MNDR | hsa-miR-181d-5p | Multiple myeloma | MNDR-E-MI-20175 |
| MNDR | hsa-miR-181d-5p | Nasopharyngeal cancer | MNDR-E-MI-20176 |
| MNDR | hsa-miR-181d-5p | Epstein-barr virus infections | MNDR-E-MI-20177 |
| MNDR | hsa-miR-181d-5p | Stroke | MNDR-E-MI-20178 |
| MNDR | hsa-miR-181d-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-20179 |
| MNDR | hsa-miR-181d-5p | HPV | MNDR-E-MI-20180 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BCL2 | Homo sapiens | RR00219009 |
TOP